Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_15058d3e539540e50d7d7168ab007717 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cc6a33a5abb5d89460358f1119b06ca2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7c41e9134a80b7240a43e2d1b065474 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ccf195fa14944c988e27a96984c7664 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-6439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2458-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-582 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-6428 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
filingDate |
2010-07-19^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2014-11-04^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80a71e7c466431e447115d0a313150fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a66e68e78d845b6803a545b950cb6662 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03ea4a6a1171e9f01075d65ed7b2ea40 |
publicationDate |
2014-11-04^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8877509-B2 |
titleOfInvention |
System and method for analyzing samples labeled with 5, 10, 15, 20 tetrakis (4-carboxyphenyl) porphine (TCPP) |
abstract |
One embodiment of the present invention provides for a method of determining if a sputum sample contains dysplastic or carcinomic cells by obtaining a sputum sample containing cells. The sputum sample is labeled with TCPP to stain cells suspected to be dysplastic or carcinomic. The labeled sputum sample is excited with an excitation wavelength of light of about 475 nm+/−30 nm and emission at about 560 nm+/−30 nm is detected from cells identified to be macrophages. An imager focuses on the plasma membrane of one or more cells suspected to be dysplastic or carcinomic and emission at about 655 nm+/−30 nm, if present, is detected for TCPP labeled cells of the sputum sample after focusing on the plasma membrane of the cells of the sputum sample. Photon flux for each pixel of a sensor is measured to obtain a value for the imaged cell. The measured value is scored to determine if a cell is cancerous or dysplastic. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9417241-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015177245-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015160197-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11590233-B2 |
priorityDate |
2009-07-17^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |